Advertisement
外匯新聞
South Korea Bourse May Find Support At 2,300 Points
The South Korea stock market has finished lower in three straight sessions, sinking nearly 120 points or 5 percent along the way. The KOSPI now rests just above the 2,300-point plateau although it may finally stop the bleeding on Monday.
RTTNews |
1074天前
Australia Home Loan Data Due On Monday
Australia will on Monday release May figures for home loans and building permits, highlighting a light day for Asia-Pacific economic activity.
RTTNews
|
1074天前
Swiss Market Ends Modestly Higher On Late Buying
Despite spending much of the day's session in the red, the Switzerland stock market ended modestly higher on Friday thanks to some selective buying at a few counters in the final hour.
RTTNews
|
1077天前
European Stocks End On Mixed Note After Choppy Session
European stocks ended on a mixed note on Friday after a somewhat choppy session with investors looking for directional clues and making largely cautious moves amid persisting worries about rate hikes and a possible recession.
RTTNews
|
1077天前
U.S. Dollar Higher On Growth Concerns
The U.S. dollar moved up against its major counterparts in the European session on Friday, as European stocks fell on growing worries about a recession in the wake of a faster policy tightening by major central banks to curb soaring inflation.
RTTNews
|
1077天前
U.S. Construction Spending Unexpectedly Edges Down 0.1% In May
Reflecting a decrease in spending on public construction, the Commerce Department released a report on Friday showing an unexpected dip in U.S. construction spending in the month of May. The report showed construction spending edged down by 0.1 percent to an annual rate of $1.780 trillion in May after climbing by 0.8 percent to an upwardly revised rate of $1.783 trillion in April.
RTTNews
|
1077天前
U.S. Manufacturing Index Drops To Two-Year Low In June
The Institute for Supply Management released a report on Friday showing its reading on U.S. manufacturing activity fell to its lowest level in two years in the month of June. The ISM said its manufacturing PMI slid to 53.0 in June from 56.1 in May, although a reading above 50 still indicates growth in the sector. Economists had expected the index to dip to 54.9.
RTTNews
|
1077天前
more news
Eurozone Inflation Reaches New Record High
Eurozone inflation accelerated further to a new record high in June, while core inflation unexpectedly moderated due to the fiscal support measures to contain energy prices, official data showed Friday. The harmonized index of consumer prices advanced more-than-expected by 8.6 percent on a yearly basis in June, faster than the 8.1 percent rise in May, flash data from Eurostat showed on Friday.
RTTNews
|
1077天前
Eurozone Manufacturing Growth Weakest In Nearly 2 Years
The eurozone manufacturing activity grew at the weakest pace in nearly two years in June on weaker production and new orders, final data from S&P Global showed Friday.
The manufacturing Purchasing Managers' Index fell to a 22-month low of 52.1 in June from 54.6 in May. The flash score was 52.0. The headline figure dropped for the fifth consecutive month in June.
RTTNews
|
1077天前
Teva Pharmaceutical Appoints Eric Hughes As Chief Medical Officer
Teva Pharmaceutical Industries Ltd. (TEVA) announced Friday the appointment of Dr. Eric Hughes, MD, PhD as Executive Vice President, Global R&D and Chief Medical Officer. Hughes will begin his employment on August 1, 2022, and will be based out of Teva's U.S. headquarters in Parsippany, New Jersey.
RTTNews
|
1077天前
Bay Street Seen Opening On Cautious Note
Lower U.S. and Canadian futures and choppy European stocks point to a cautious start on Bay Street Friday morning.
RTTNews
|
1077天前
Endo Int'l Reports Top-line Results From Phase 2 Study Of CCH For Adhesive Capsulitis Of Shoulder
Pharmaceutical company Endo International plc (ENDP) announced Friday top-line results from its Phase 2 study of Collagenase Clostridium Histolyticum (CCH) in participants with adhesive capsulitis (AC) of the shoulder, commonly known as "frozen shoulder."
RTTNews
|
1077天前
Regeneron Completes Acquiring Sanofi's Stake In Libtayo
Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.
RTTNews
|
1077天前
Stay up to date!
Add 新聞 to your browser
Add To Chrome
